Innogenetics Group

Contact
fujirebio-europe.com
+32-93291329

Fujirebio Europe N.V.

Technologiepark 6
9052 Gent
Belgium
+32-93291329
fujirebio-europe.com
Contact
Profile Products News
Contact

About Innogenetics Group

Innogenetics capitalizes on her expertise to provide diagnostic and therapeutic products that address pressing medical needs. Innogenetics operates a global specialty diagnostics business focusing on infectious diseases, genetic testing, and neurodegeneration. In parallel, Innogenetics strives to develop novel therapeutic vaccines, a promising approach in the field of infectious diseases for which current therapeutic options are limited.

Read more about Innogenetics Group
Facts about Innogenetics Group
  • Founding: 1985
  • Focus : Manufacturer
  • Employees: 201-500
  • Industry : Diagnostics

Product portfolio of Innogenetics Group

Product portfolio

Show all

News about Innogenetics Group

Innogenetics Group

20-Oct-2008 | business & finance

Solvay Group holds 93.1% of Innogenetics shares

Offer on Innogenetics shares is extended from 22 October to 12 November

Read news
Innogenetics Group

11-Sep-2008 | business & finance

Solvay Pharmaceuticals acquires Innogenetics

Solvay Group holds 84.3% of Innogenetics shares

Read news
Innogenetics Group

03-Jul-2008 | business & finance

Innogenetics grants GlaxoSmithKline Biologicals a license for use of HPV SPF10 genotyping technology in clinical studies on HPV

Innogenetics announced that it has granted GlaxoSmithKline Biologicals (GSK) a worldwide non-exclusive restricted license to use its proprietary SPF10 ...

Read news
Innogenetics Group

04-Jun-2008 | research and development

Innogenetics achieves CE mark for new human papillomavirus (HPV) genotyping test

Innogenetics announced that it has received CE marking for its new and expanded HPV genotyping test, the INNO-LiPA HPV Genotyping Extra. The new generation ...

Read news
Innogenetics Group

03-Jun-2008 | business & finance

Innogenetics announces definitive closure of GENimmune

Innogenetics announced the final phase of its restructuring plan for the pharma division of GENimmune. In accordance with the collective labor agreement ...

Read news
Innogenetics Group

29-Apr-2008 | business & finance

Solvay Pharmaceuticals S.A. launches friendly bid to acquire Innogenetics

Building on a successful R&D co-operation

Read news
Innogenetics Group

10-Apr-2008 | business & finance

Innogenetics and Solvay Pharmaceuticals extend collaboration for biomarker discovery

Innogenetics announced a 2-year extension of its longstanding research collaboration with Solvay Pharmaceuticals. Since November 1997, Solvay and ...

Read news
Innogenetics Group

14-Feb-2008 | business & finance

Innogenetics announces the intention to restructure its subsidiary GENimmune

Last year, Innogenetics decided to focus on the development and sales of diagnostic products, and GENimmune N.V. was incorporated as a fully owned ...

Read news
Show more news about Innogenetics Group

Here you will find Fujirebio Europe N.V.